WallStreetZenWallStreetZen

NASDAQ: SNOA
Sonoma Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sonoma Pharmaceuticals revenue was $14.29M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $3.8M, up 5.3% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, SNOA annual revenue was $14.3M, with 12.2% growth year-over-year.

SNOA past revenue growth

How has SNOA's revenue growth performed historically?

Company
12.19%
Industry
10.05%
Market
37.33%
SNOA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNOA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNOA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNOA revenue history

Current Revenue
$14.3M
Current Earnings
-$3.5M
Current Profit Margin
-24.2%

Be the first to know when SNOA announces revenue.

SNOA Revenue History By Year

SNOA Yearly RevenueSNOA RevenueSNOA ChangeSNOA Revenue Growth
2025-03-31$14.29M$1.55M+12.19%
2024-03-31$12.74M-$537.00k-4.05%
2023-03-31$13.27M$644.00k+5.10%
2022-03-31$12.63M-$6.00M-32.21%
2021-03-31$18.63M$701.00k+3.91%
2020-03-31$17.93M-$1.04M-5.49%
2019-03-31$18.97M$2.31M+13.88%
2018-03-31$16.66M$3.83M+29.89%
2017-03-31$12.83M$3.46M+36.89%
2016-03-31$9.37M-$4.49M-32.37%
2015-03-31$13.85M$186.00k+1.36%
2014-03-31$13.67M-$1.78M-11.55%
2013-03-31$15.45M$2.71M+21.25%
2012-03-31$12.74M$2.99M+30.65%
2011-03-31$9.75M$2.39M+32.46%
2010-03-31$7.36M$1.98M+36.67%
2009-03-31$5.39M$1.55M+40.50%
2008-03-31$3.84M-$708.00k-15.58%
2007-03-31$4.54M$1.96M+75.81%
2006-03-31$2.58M$1.23M+90.56%
2005-03-31$1.36M$454.00k+50.33%
2004-03-31$902.00kN/AN/A

1 of 2

Sonoma Pharmaceuticals Revenue FAQ

What was SNOA's revenue last quarter?

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q1 2025 revenue of $3.75 million up 9.16% year over year. In the same quarter last year, Sonoma Pharmaceuticals's revenue was $3.44 million.

What was Sonoma Pharmaceuticals's revenue in 2025?

Sonoma Pharmaceuticals's annual revenue for the twelve months ending Mar 31, 2025 was $14.29 million, a 12.19% increase year over year.

How much does Sonoma Pharmaceuticals make in a day?

Based on Sonoma Pharmaceuticals annual revenue for the past five years, SNOA makes an average of $39,206.58 per day.

What was Sonoma Pharmaceuticals's annual revenue growth in the past year?

As of Q3 2025, Sonoma Pharmaceuticals's revenue has grown 12.19% year over year. This is 2.15 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.05%. Sonoma Pharmaceuticals's revenue in the past year totaled $14.29 million.

How much does Sonoma Pharmaceuticals make in a year?

Sonoma Pharmaceuticals's revenue by year for the past five years is:
  • Sonoma Pharmaceuticals's revenue for the twelve months ending Mar 31, 2025 was $14.29 million, a 12.19% increase year over year.
  • Sonoma Pharmaceuticals's annual revenue for Mar 31, 2024 was $12.74 million, a 4.05% decrease from 2023.
  • Sonoma Pharmaceuticals's annual revenue for 2023 was $13.27 million, a 5.1% increase from 2022.
  • Sonoma Pharmaceuticals's annual revenue for 2022 was $12.63 million, a 32.21% decrease from 2021.
  • Sonoma Pharmaceuticals's annual revenue for 2021 was $18.63 million, a 3.91% increase from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.